Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-12

Clinical Trial Update: Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating quetiapine fumarate as both monotherapy and as an adjunct to lithium for acute mania in bipolar disorder; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Acute Mania in Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2012-07-12